Is only worth a penny??
If,as Dr. Kim said "The end of the year should show great progress",and we are 10 years ahead of the rest "Fast track" by default..
Sentiment: Strong Buy
Worldwide, the market for cervical cancer screening and diagnostics, as currently practiced using cytology (Pap test) for primary screening, is estimated at $6 billion and is projected to grow to almost $9 billion by 2020. There are about 2.6 billion women aged 15 years and older who are at risk of developing cervical cancer worldwide.
About LuViva® Advanced Cervical Scan
Growing International Momentum for LuViva
The company also recently announced shipments of the LuViva Advanced Cervical Scan to Indonesia, Bangladesh, Bulgaria and Nigeria — all countries that are targeted for screening.
On January 28, the Company announced that the Nairobi County Health Services Sector had agreed to purchase an additional five LuViva Advanced Cervical Scans for use in the agency’s cervical cancer screening program. The following headlines link to LuViva stories in the media:
If they had the imagination...I wouldn't mind $ 10.00 a share..They do have the goods..
There should be a repeat, I can say it was very positive..try to find it on the web site or email ino for directions to it.It will be worth it..Good luck!
warned that development typically took 10 to 15 years. INOVIO said it will be ready by the END OF THE YEAR..and your selling..?? SSB
50.00 pluss per share..If it ever brings that,that in itself may prove it to be worth more ..exciting times ahead.. SSB
Others warned that development typically took 10 to 15 years. Sanofi is also exploring developing a vaccine, according to Reuters. see the advantage..made in weeks..potentially ready buy the end of the year for testing on humans..